Dec 9 (Reuters) - CVS Health (CVS) on Tuesday forecast 2026 profit above Wall Street estimates and this year's projected earnings, signalling steady progress in the health conglomerate's turnaround plan.
CVS stock rose 5% in early trading on Tuesday.
The company in October projected double-digit earnings growth for 2026 after raising its 2025 profit forecast for the third time.
"We are closing out 2025 with meaningful momentum across our businesses and we expect another year of strong earnings growth in 2026," said Chief Financial Officer Brian Newman on Tuesday.
The company forecast 2026 adjusted profit to be in the range of $7.00 to $7.20 per share, compared with analysts' average estimate of $7.16, according to data compiled by LSEG.
It, however, expects total revenue of at least $400 billion next year, below analysts' average estimate of $419.26 billion.
CVS also raised its 2025 adjusted profit forecast to $6.60 to $6.70 per share from $6.55 to $6.65 previously.
(Reporting by Sneha S K in Bengaluru; Editing by Shinjini Ganguli)
latest_posts
- 1
Moon-bound Artemis II astronauts enjoy a relaxed day in space - 2Dental, Vision, and Hearing Inclusion in Senior Protection.
- 3Gym tied to outbreak of obscure disease that spreads through mist
- 4Russia accidentally destroys its only way of sending astronauts to space
- 5Cyprus: War-related tourism concerns and climate change efforts
- Iranian-backed militias escalate in Iraq, targeting Kurdistan Region president Nechirvan Barzani
- Make your choice for a definitive Christmas place to get-away!
- Well known Travel Booking Locales: What's Your Pick?
- Flourishing in a Cutthroat Work Market: Vocation Methodologies
- Radiated Tortoise Faces Rapid Decline in Madagascar
- The Best Business visionaries Under 30
- Instructions to Utilize the Towing Highlights of the Slam 1500 Productively.
- Ancient fire discovery marks significant milestone in human history
- Manual for 6 well known Amusement Park
